Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.13 USD | -0.11% | -4.53% | +29.43% |
05-09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
05-08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.43% | 6.13B | |
+29.76% | 48.16B | |
-0.74% | 41.73B | |
+43.85% | 41.03B | |
-5.31% | 28.77B | |
+10.56% | 25.59B | |
-22.52% | 18.96B | |
+8.85% | 12.92B | |
+28.57% | 12.03B | |
-2.51% | 11.77B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Oppenheimer Adjusts Revolution Medicines Price Target to $35 From $30, Maintains Outperform Rating